Search Page

1

Cite

Share

Non-steroidal anti-inflammatory drugs for acute gout.

van Durme CM, Wechalekar MD, Landewé RB, Pardo Pardo J, Cyril S, van der Heijde D, Buchbinder R. van Durme CM, et al. Cochrane Database Syst Rev. 2021 Dec 9;12(12):CD010120. doi: 10.1002/14651858.CD010120.pub3. Cochrane Database Syst Rev. 2021. PMID: 34882311 Review.

Cite

Share

2

Cite

Share

Dripping candle wax.

van Durme CM, Starmans-Kool MJ, Peeters HR. van Durme CM, et al. Neth J Med. 2012 Apr;70(3):140, 143. Neth J Med. 2012. PMID: 22516580 Free article. No abstract available.

Cite

Share

3

Cite

Share

Multiple endocrine abnormalities.

van Durme CM, Kisters JM, van Paassen P, van Etten RW, Tervaert JW. van Durme CM, et al. Lancet. 2011 Aug 6;378(9790):540. doi: 10.1016/S0140-6736(11)60831-3. Lancet. 2011. PMID: 21821186 No abstract available.

Cite

Share

4

Cite

Share

Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study.

Te Kampe R, Janssen M, van Durme C, Jansen TL, Boonen A. Te Kampe R, et al. Among authors: van durme c. J Rheumatol. 2021 Feb;48(2):286-292. doi: 10.3899/jrheum.200113. Epub 2020 Jul 1. J Rheumatol. 2021. PMID: 32611671

Cite

Share

5

Cite

Share

Treatment of gout patients with impairment of renal function: a systematic literature review.

van Echteld IA, van Durme C, Falzon L, Landewé RB, van der Heijde DM, Aletaha D. van Echteld IA, et al. Among authors: van durme c. J Rheumatol Suppl. 2014 Sep;92:48-54. doi: 10.3899/jrheum.140462. J Rheumatol Suppl. 2014. PMID: 25180128 Review.

Cite

Share

6

Cite

Share

Non-steroidal anti-inflammatory drugs for acute gout.

van Durme CM, Wechalekar MD, Buchbinder R, Schlesinger N, van der Heijde D, Landewé RB. van Durme CM, et al. Cochrane Database Syst Rev. 2014 Sep 16;(9):CD010120. doi: 10.1002/14651858.CD010120.pub2. Cochrane Database Syst Rev. 2014. PMID: 25225849 Updated. Review.

Cite

Share

7

Cite

Share

Obstructive sleep apnea and the risk of gout: a population-based case-control study.

van Durme C, Spaetgens B, Driessen J, Nielen J, Sastry M, Boonen A, de Vries F. van Durme C, et al. Arthritis Res Ther. 2020 Apr 25;22(1):92. doi: 10.1186/s13075-020-02176-1. Arthritis Res Ther. 2020. PMID: 32334617 Free PMC article.

Cite

Share

8

Cite

Share

Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literature.

van Durme C, van Echteld IA, Falzon L, Aletaha D, van der Heijde DM, Landewé RB. van Durme C, et al. J Rheumatol Suppl. 2014 Sep;92:9-14. doi: 10.3899/jrheum.140457. J Rheumatol Suppl. 2014. PMID: 25180123 Review.

Cite

Share

9

Cite

Share

Comparative Study of Real-Life Management Strategies in Gout: Data From Two Protocolized Gout Clinics.

Te Kampe R, van Durme C, Janssen M, van Eijk-Hustings Y, Boonen A, Jansen TL. Te Kampe R, et al. Among authors: van durme c. Arthritis Care Res (Hoboken). 2020 Aug;72(8):1169-1176. doi: 10.1002/acr.23995. Epub 2020 Jun 11. Arthritis Care Res (Hoboken). 2020. PMID: 31150161

Cite

Share

10

Cite

Share

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.

Sivera F, Andrés M, Carmona L, Kydd AS, Moi J, Seth R, Sriranganathan M, van Durme C, van Echteld I, Vinik O, Wechalekar MD, Aletaha D, Bombardier C, Buchbinder R, Edwards CJ, Landewé RB, Bijlsma JW, Branco JC, Burgos-Vargas R, Catrina AI, Elewaut D, Ferrari AJ, Kiely P, Leeb BF, Montecucco C, Müller-Ladner U, Ostergaard M, Zochling J, Falzon L, van der Heijde DM. Sivera F, et al. Among authors: van durme c. Ann Rheum Dis. 2014 Feb;73(2):328-35. doi: 10.1136/annrheumdis-2013-203325. Epub 2013 Jul 18. Ann Rheum Dis. 2014. PMID: 23868909 Free PMC article.

Cite

Share